2020
DOI: 10.1002/bio.3948
|View full text |Cite
|
Sign up to set email alerts
|

Bioluminescence goes portable: recent advances in whole‐cell and cell‐free bioluminescence biosensors

Abstract: Recent advancements in synthetic biology, organic chemistry, and computational models have allowed the application of bioluminescence in several fields, ranging from well established methods for detecting microbial contamination to in vivo imaging to track cancer and stem cells, from cell‐based assays to optogenetics. Moreover, thanks to recent technological progress in miniaturized and sensitive light detectors, such as photodiodes and imaging sensors, it is possible to implement laboratory‐based assays, such… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 122 publications
0
5
0
Order By: Relevance
“…Previous reports suggested that the PIK3CA promoter has binding sites for both p53 and NF-κB [33,34]. Also, in EOC cells, it was shown that p53 acts as a transcriptional repressor of the PIK3CA promoter by directly binding to its promoter sequence [36], whereas in the case of cisplatin-resistant EOC cells, enhanced NF-κB activity is required to develop acquired chemoresistance [14,16]. However, to date, it was unknown whether NF-κB activation may exert indirect control on p53 protein activation and thereby may alter PIK3CA gene regulation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous reports suggested that the PIK3CA promoter has binding sites for both p53 and NF-κB [33,34]. Also, in EOC cells, it was shown that p53 acts as a transcriptional repressor of the PIK3CA promoter by directly binding to its promoter sequence [36], whereas in the case of cisplatin-resistant EOC cells, enhanced NF-κB activity is required to develop acquired chemoresistance [14,16]. However, to date, it was unknown whether NF-κB activation may exert indirect control on p53 protein activation and thereby may alter PIK3CA gene regulation.…”
Section: Discussionmentioning
confidence: 99%
“…It is also worth noting some of the recent development of luciferase-based sensors for in vivo imaging, cell tracking, and biochemical assays [11][12][13]. Luciferases have been used to detect various inhibitors and bioactive products by using handheld devices as well [14]. In particular, NLuc has been used as a sensor for detecting specific DNA or RNA sequences which can be used as a diagnostic tool for disease biomarkers detection [15].…”
Section: Introductionmentioning
confidence: 99%
“…The ability to emit photons without the need of photoexcitation renders BL highly appealing for the implementation into portable and miniaturized devices. BL provided a formidable manifold system relying on different luciferases and luciferin analogues with a wide range of applications spanning from molecular imaging to biosensor development [12][13][14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…Numerical modelling currently supports the frontier development and application of various scientific and engineering disciplines. There are many numerical modelling and ray-tracing methods that have been developed based on established modelling techniques for luminescence in microfluidic or portable systems [49][50][51][52][53][54]. These methods include applications for analytes of environmental [43,55,56], clinical [49,50,52,57], and forensic interest [53].…”
Section: Introductionmentioning
confidence: 99%
“…There are many numerical modelling and ray-tracing methods that have been developed based on established modelling techniques for luminescence in microfluidic or portable systems [49][50][51][52][53][54]. These methods include applications for analytes of environmental [43,55,56], clinical [49,50,52,57], and forensic interest [53]. Here we present the foundations of best practices for developing novel radiometric prototypes.…”
Section: Introductionmentioning
confidence: 99%